Amani D. Piers

Amani D. Piers

Auto-generated profile, based on publicly available information

Amani D. Piers

Department of Psychology, Drexel University, Philadelphia, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

30 March 2023 in Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity
Verified
Journal Article
Open access
PDF file
MPMegan Parker
Megan Parker
HMHelen Burton Murray
Helen Burton Murray
APAmani D. Piers
Amani D. Piers
AMAlexandra Muratore
Alexandra Muratore
MLMichael R. Lowe
Michael R. Lowe
AJAdrienne S. Juarascio
Adrienne S. Juarascio
Purpose: Difficulty reappraising drives to consume palatable foods may promote poorer inhibition and binge eating (BE) in adults with obesity, but neural underpinnings of food-related reappraisal are underexamined. Methods: To examine neural correlates of food-related reappraisal, adults with obesity with and without BE wore a portable neuroimaging tool, functional near-infrared spectroscopy (fNIRS). fNIRS measured activity in the prefrontal cortex while participants watched videos of food and attempt to “resist” the food stimuli (i.e., “consider the negative consequences of eating the food”). Results: Participants (N = 32, 62.5% female; BMI 38.6 $$\pm$$ ± 7.1; 43.5 $$\pm$$ ± 13.4 y) had a BMI > 30 kg/m2. Eighteen adults (67.0% female; BMI 38.2 $$\pm$$ ± 7.6) reported BE (≥ 12 BE-episodes in preceding 3 months). The control group comprised 14 adults who denied BE (64.0% female; BMI 39.2 $$\pm$$ ± 6.6). Among the entire sample, mixed models showed significant, small hyperactivation during crave and resist compared to watch (relax) condition bilaterally in the medial superior frontal gyrus, dorsolateral areas, and middle frontal gyrus (optodes 5, 7, 9, 10, 11, and 12) in the total sample. No statistically significant differences in neural activation were observed between the BE and control group. Moreover, there were no significant group by condition interactions on neural activation. Conclusion: Among adults with obesity, BE status was not linked to differential activation in inhibitory prefrontal cortex areas during a food-related reappraisal task. Future research is needed with larger samples, adults without obesity, and inhibition paradigms with both behavioral and cognitive components. Level of evidence: Level III: Evidence obtained from well-designed cohort or case–control analytic studies. Trial registration: # NCT03113669, date April 13, 2017.

31 March 2022 in Appetite
Verified
Journal Article
Closed access
JCJoanna Y. Chen
Joanna Y. Chen
APAmani D. Piers
Amani D. Piers
ELElin L. Lesser
Elin L. Lesser
MLMichael R. Lowe
Michael R. Lowe

16 July 2021
Verified
Thesis
Closed access
APAmani D. Piers
Amani D. Piers
MLMichael R. Lowe
Michael R. Lowe
There is a pressing need to improve standard behavioral weight loss (BWL) programs to improve both short-term and long-term weight loss outcomes. One limitation of current BWL programs is that they rely heavily on participants' own self-control to make and sustain major changes to their diet and overall energy intake. However, the reliability of willpower alone to maintain weight loss has been called into question; over time, when weight loss slows and motivation drops, adherence to the implementation of core BWL skills and principles may drop and lead to weight regain. Increased structure and targeted skills designed to shift the burden away from self-control could help improve dietary intake and weight loss outcomes in BWL. The current study aimed to investigate changes in the home food environment and dietary intake across three weight loss conditions: standard behavior therapy, behavior therapy plus meal replacement provisions, and behavior therapy supplemented with nutritional and food environment counseling (Nutritrol). Across all three conditions, results showed that participants were able to make positive quantitative (i.e., reductions in overall energy intake) and qualitative (e.g., decrease in percentage of energy intake coming from fat) changes over the course of the intervention, although the sustainability of these changes in the follow-up period was mixed. Over time, Nutritrol showed a meaningful advantage over the other conditions regarding the percentage of intake that came from carbohydrates and fats, and the overall amount of fiber that was consumed. Contrary to our hypotheses, no other differences were detected in dietary quality, quantity of energy intake, or obesogenic nature of the home food environment between conditions. Possible explanations for these lack of significant findings, including measurement tool limitations or insufficient treatment doses, are discussed.

4 February 2022
Verified
Thesis
Closed access
APAmani D. Piers
Amani D. Piers
MLMichael R. Lowe
Michael R. Lowe
Although eating disorders (EDs) have long been considered biopsychosocial disorders, the field has typically treated biological and weight-related complications as unfortunate consequences of the psychopathology of EDs. However, a growing body of research shows that weight-related variables may have an influence the development and maintenance of EDs independently of cognitive and affective dysfunctions. A yet-unexplored aspect of weight and weight trajectories in this population is within-subject weight variability (WV; i.e., the magnitude of the fluctuations in weight around the trend line of weight change over time). The current study aimed to explore the construct of WV in a transdiagnostic sample of individuals with EDs receiving treatment for their disorder. Importantly, body weights assessed in the study were collected during a residential stay, where patients are provided with all the food they consume, and both dieting and binge eating are proscribed. We aimed to characterize treatment WV in this sample, and examine how it related to ED pathology and weight trajectory over time (i.e., both during treatment and six months after discharge) in Anorexia Nervosa-spectrum (AN-spectrum) and Bulimia Nervosa-spectrum (BN-spectrum) patients. We calculated WV in two ways: "early treatment WV," using data only from patients' first 16 days in treatment, and "full treatment WV," using weights from the entire length of stay, to test whether the method of calculating WV would impact our results. In both diagnostic subsamples (n = 311 women with AN-spectrum disorders and n = 165 women with BN-spectrum disorders), full treatment WV was greater than early treatment WV (i.e., WV increased over the course of treatment). WV values were similar between diagnostic subgroups. Only full treatment WV was significantly related to pre-treatment ED symptoms, including global ED pathology, purging frequency, and weight suppression in both diagnostic subsamples, and eating concerns and restraint in the AN-spectrum subsample. In the AN-spectrum subsample, higher full treatment WV predicted more weight gain in treatment and at six-month follow up. There were no effects of WV on change in ED symptoms during treatment. As the first investigation into WV in a sample of individuals with EDs, results from this project have important implications for the growing field investigating weight and biological variables on the symptoms and maintenance of EDs. We posit that weight trajectories, including those calculated over a short period of time as in the current study, should be integrated into the understanding of the role of weight regulation in EDs. Results also highlight important methodological considerations for calculating WV and other weight-related variables in ongoing research.